0800 – 0845 (GMT+8)

Title Value of Syndromic Testing in Managing Healthcare Associated Infections
Details Date: 31 July 2022 (Sunday)
Time: 0800 – 0845
Venue: Suntec Singapore Convention & Exhibition Centre, Hall 406D, Level 4
Faculty Dr Asok Kurup, Singapore

Dr Asok Kurup is an Infectious Disease Physician at Mount Elizabeth Medical Centre, Singapore, and Visiting Consultant at the Department of Infectious Diseases, Singapore General Hospital. He is the current Chair of the Antimicrobial Stewardship Taskforce Committee Parkway Pantai Hospitals. Dr Kurup is the current Chairman of the Chapter of Infectious Disease Physicians, Academy of Medicine, Singapore, and has been a committee member of the Society of Infectious Disease (Singapore) since 2012. His research interests include community and nosocomial infections and HIV.

Title BD Satellite Symposium
Details Date: 31 July 2022 (Sunday)
Time: 0800 – 0845
Venue: Suntec Singapore Convention & Exhibition Centre, Hall 405B, Level 4
Schedule Time Description/Title Speaker
0800 – 0830 How to Enhance Your SSI Prevention Bundle Dr. David Jay Weber
0830 – 0840 ChloraPrep™ versus Aqueous Povidone Iodine: Can we expect a cost savings? Kristin Tan
0840 – 0845 Q&A
How to Enhance Your SSI Prevention Bundle
Synopsis Surgical site infections are associated with increased length of stay, readmission, and mortality. This session will highlight best practices on developing and implementing surgical site infection (SSI) reduction and prevention bundles.
Objectives · Learn elements of SSI reduction and prevention bundles

· Explore avenues on how to enhance your current SSI prevention bundles

Faculty Dr. David Jay Weber, United States

Dr. David Jay Weber is currently the Charles Addison and Elizabeth Ann Sanders Distinguished Professor of Medicine, Pediatrics and Epidemiology, University of North Carolina, Chapel Hill, NC, USA.  Dr. Weber received his Medical Degree from the University of California, San Diego in 1977, a Master’s in Public Health from Harvard University in 1985 and completed his medicine residency and infectious disease fellowship at the Massachusetts General Hospital in 1985.  He is Board Certified in Internal Medicine, Infectious Disease, Critical Care Medicine, and Preventive Medicine.  Dr. Weber serves as an Associate Chief Medical Officer and Medical Director of Infection Prevention for the UNC Medical Center.  He is the Secretary of the Board of the Society for Healthcare Epidemiology of America and the Deputy Editor of Infection Control & Hospital Epidemiology.  Dr. Weber has published more than 515 scientific papers in the peer-reviewed literature cited in PubMed and more than 650 total papers and chapters.  His research interests include the epidemiology of healthcare-associated infections, disinfection and sterilization, new and emerging infectious diseases (highly communicable pathogens including SARS-CoV-2, newly emerging pathogens including Candida auris), response to biothreats, nontuberculous mycobacteria, control of drug resistant pathogens, immunization practices, zoonotic diseases, and epidemiology of tuberculosis.

ChloraPrep™ versus Aqueous Povidone Iodine: Can we expect a cost savings?
Synopsis Studies have shown that preoperative skin preparation with ChloraPrep™ for colorectal procedures can reduce SSIs. What are the clinical and economic impact of adopting ChloraPrep™?
Objectives Compare the costs and SSI outcomes for adopting ChloraPrep™ versus bulk aqueous povidone iodine solution in colorectal procedures
Faculty Kristin Tan, Singapore

Kristin Tan is currently the Health Economics & Market Shaping Manager, Strategic Access, Greater Asia Public Affairs at BD. She holds a Master of Public Health and a Bachelor of Science with Honours (double major in Statistics and Economics) from the National University of Singapore. Kristin has over ten years of experience in statistical modelling, economic evaluation, epidemiological studies and quantitative research in the academia and the pharmaceutical and medical device industry.